criver.com (CRL) - Company Sales

Charles River Laboratories (CRL) maintains its leadership in the preclinical sector through integration into client R&D, although biotech budget cuts and a shortage of models create risks. The company's sales volume dynamics confirm business resilience, where 3.98 is recorded as the baseline value. Its high status and cutting-edge laboratories enable the attraction of top toxicologists who build their careers through significant research.

Charles River Lab (CRL) - Revenue and Sales Volume from 07/04/2022 to 11/15/2026

Analytical breakdowns for Charles River Laboratories

- market value and analyst target forecast:

Market Chart Charles River Laboratories|CRL - Analyst Consensus Forecast

- market capitalization indicators:

Market Valuation Charles River Laboratories International, Inc.|CRL - Enterprise Value

- balance sheet equity data:

Accounting Value of a Share Charles River|CRL - Book Capitalization|Market Capitalization to Book Value Ratio criver.com|CRL - Aggregate Company Assets

- debt and solvency information:

- earnings and valuation multiples indicators:

CRL - Company Net Income|Expected Net Income Charles River Laboratories|CRL - P/E Multiple|Market Cap to Projected Earnings Charles River Lab|CRL - Price/Earnings to Growth Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Charles River Laboratories International, Inc.|CRL - Operating profit EBITDA|Net earnings per one share for the last twelve months Charles River|CRL - Earnings per share for the last twelve months|Year-over-year earnings per one share growth for the last 12 months criver.com|CRL - Net earnings per share growth this year|Expected earnings per share trend next year Charles River Laboratories

- company sales and revenue statistics:

CRL - Company Revenue|Company Projected Revenue Charles River Laboratories|CRL - P/S Multiple|Forward P/S Multiple Charles River Laboratories International, Inc.|CRL - Sales Growth YoY (TTM)

Summary company analysis:CRL (criver.com)

Flagship merchandise of Charles River Laboratories International, Inc.

This indicator reflects the daily revenue of the enterprise, smoothing out short-term fluctuations to identify the true dynamics of cash inflows. By analyzing the sales growth rate of Charles River Laboratories (CRL), an investor assesses the financial stability of the business, which in the case of Charles River Laboratories (CRL) is based on the monopoly ownership of rare expert competencies and strict adherence to international preclinical research protocols.

Analysis of competing companies